Suppr超能文献

结直肠癌筛查的有效性:德国萨尔州一项基于人群的病例对照评估结果

Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany.

作者信息

Wahrendorf J, Robra B P, Wiebelt H, Oberhausen R, Weiland M, Dhom G

机构信息

German Cancer Research Center, Division of Epidemiology, Heidelberg.

出版信息

Eur J Cancer Prev. 1993 May;2(3):221-7.

PMID:8490540
Abstract

In order to evaluate the effectiveness of colorectal cancer screening by the faecal occult blood test (FOBT) in Germany a population-based case-control study was conducted in Saarland, a southwestern state of Germany. As cases, we identified 522 persons (244 males, 278 females) who died of colorectal cancer between 1983 and 1986 between the ages of 55 and 75 years. For 163 male cases complete screening histories were retrieved together with up to five age-matched controls who had not died of colorectal cancer identified from the files of the case's referring general practitioner (GP). For 209 female cases screening histories were retrieved from their GPs and gynaecologists as well as for age-matched controls. Individual screening histories were established with emphasis on identifying whether FOBTs were carried out asymptomatically or symptomatically. In the time period 6-36 months prior to diagnosis 13% of the male cases and 14% of the male controls had at least one asymptomatic FOBT with a corresponding matched odds ratio of 0.92 (95% CI: 0.61, 1.75). For the same prediagnostic period 16% of the female cases and 29% of the female controls had at least one asymptomatic FOBT leading to an odds ratio of 0.43 (95% CI: 0.27, 0.68). Thus, for males where participation rates are generally low, no protective effect could be seen but for females where participation rates are higher a clear protective effect is seen. Possibilities for bias need to be taken into consideration when interpreting these results. Organizational measures ensuring a high penetrance of a mass screening programme are seen as a way to elevate efficacy.

摘要

为评估德国粪便潜血试验(FOBT)用于结直肠癌筛查的有效性,在德国西南部的萨尔州开展了一项基于人群的病例对照研究。作为病例,我们确定了522人(244名男性,278名女性),他们在1983年至1986年间死于结直肠癌,年龄在55岁至75岁之间。对于163名男性病例,从病例转诊的全科医生(GP)档案中检索了完整的筛查史以及多达五名未死于结直肠癌的年龄匹配对照。对于209名女性病例,从她们的全科医生和妇科医生处检索了筛查史以及年龄匹配对照。建立了个人筛查史,重点是确定FOBT是无症状进行还是有症状进行。在诊断前6至36个月期间,13%的男性病例和14%的男性对照至少进行了一次无症状FOBT,相应的匹配比值比为0.92(95%CI:0.61,1.75)。在相同的诊断前期,16%的女性病例和29%的女性对照至少进行了一次无症状FOBT,导致比值比为0.43(95%CI:0.27,0.68)。因此,对于参与率普遍较低的男性,未观察到保护作用,但对于参与率较高的女性,观察到了明显的保护作用。在解释这些结果时需要考虑偏倚的可能性。确保大规模筛查计划高普及率的组织措施被视为提高疗效的一种方式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验